Strategy and Measurement for Prevention and Control of Hypertension in Canada

Dianjun Sun; Yashuang Zhao; Wei Zhang; Yanjie Lv; Ye Tian; Yong Zhang; Yanhui Gao; Xia Li; Jinming Fu; Baofeng Yang

doi:10.15302/J-SSCAE-2017.02.020

PDF(228 KB)

Strategic Study of CAE ›› 2017, Vol. 19 ›› Issue (2) : 117-121. DOI: 10.15302/J-SSCAE-2017.02.020

Study on Overseas Practice

Strategy and Measurement for Prevention and Control of Hypertension in Canada

Author information +

History +

Abstract

Hypertension is a public health issue around the world. At present, Canada is one of the few countries that have achieved remarkable success in the prevention and control of hypertension. Canada has accumulated a considerable amount of advanced experience in the control of hypertension and in the implementation of effective measures against it. This article introduces the prevalence of hypertension in Canada and the development of control strategies and measures against hypertension in Canada, including the Canadian Hypertension Society, the Canadian Hypertensive Education Program, public policies, community interventions, and healthcare systems. We summarize these advanced experiences in order to provide a policy-making basis for the development of hypertension prevention and control in China.

Keywords

hypertension / awareness rate / control rate / treatment rate

Cite this article

EndNote

Ris (Procite)

Bibtex

Download citation ▾

Dianjun Sun, Yashuang Zhao, Wei Zhang, Yanjie Lv, Ye Tian, Yong Zhang, Yanhui Gao, Xia Li, Jinming Fu, Baofeng Yang. Strategy and Measurement for Prevention and Control of Hypertension in Canada. Strategic Study of CAE, 2017, 19(2): 117‒121 https://doi.org/10.15302/J-SSCAE-2017.02.020

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	McAlister F A, Wilkins K, Joffres M, et al. Changes in the rates of awareness, treatment and control of hypertension in Canada over the past two decades [J]. Canadian Medical Association Journal，2011,183(9): 1007–1013.

[2]	Robitaille C, Dai S, Waters C, et al. Diagnosed hypertension in Canada: Incidence, prevalence and associated mortality [J]. Cana-dian Medical Association Journal，2012, 184(1): 49–56.

[3]	Schiffrin E L, Campbell N R, Feldman R D, et al. Hypertension in Canada: Past, present, and future [J]. Annals of Global Health, 2016, 82(2): 288–299.

[4]	Chockalingam A, Campbell N, Ruddy T, et al. Canadian national high blood pressure prevention and control strategy [J].Canadian Journal of Cardiology, 2000 , 16(9): 1087–1093.

[5]	Chockalingam A, Abbott D, Bass M, et al. Recommendations of the Canadian consensus conference on nonpharmacological approaches to the management of high blood pressure [J]. Cannadian Medical Association Journal, 1990,142(12): 1397–1409.

[6]	Campbell N R, Brant R, Johansen H, et al. Increases in antihypertensive prescriptions and reductions in cardiovascular events in Canada [J]. Hypertension, 2009, 53(2): 128–134.

[7]	Mcalister F A, Feldman R D, Wyard K, et al. The impact of the Canadian Hypertension Education Programme in its first decade[J]. European Heart Journal, 2009, 30(12): 1434–1439.

[8]	Campbell N R, Petrella R, Kaczorowski J. Public education on hypertension: A new initative to improve the prevention, treatment and control of hypertension in Canada[J]. Canadian Journal of Cardiology, 2006, 22(7): 599–603.

[9]	Sodium Working Group. Sodium reduction strategy for Canada: 121中国工程科学 2017 年第 19 卷第 2 期Recommendations of the sodium working group [R].

[10]	Kaczorowski J Chambers L W, Dolovich L, et al. Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP) [J]. British Medical Journal , 2011(342): d442.